Drug name - Tascenso Odt
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9925138 | HANDA | Stable solid fingolimod dosage forms |
Jan, 2036
(13 years from now) | |
| US10555902 | HANDA | Stable fingolimod dosage forms |
Jan, 2036
(13 years from now) | |
| US10925829 | HANDA | Stable solid fingolimod dosage forms |
Jan, 2036
(13 years from now) | |
Drugs and Companies using FINGOLIMOD LAURYL SULFATE ingredient
Treatment: Treatment of multiple sclerosis in pediatric patients 10 years of age and older and weighing less than or equal to 40 kg
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.25MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.